Leucine + Metformin In Phase II Human Trials | Prof Michael Zemel Ep 3
Modern Healthspan
00:00
The Future of Weight Loss Drugs
We believe with further clinical development have a drug that can be highly accessible in a form that is easily taken orally. And really hit not only on weight, but on weight associated COVID or obesity associated comorbidities and improve overall cardiometabolic health. So we're planning our next trials now. And we are quite optimistic. Our weight loss data has already repeated itself in two-phase, two trials. Now the question is how to best optimize? Excellent. How to best optimize and also longer-term trials. We have up to six months. We need to take it out to a year and move into phase three for trials of that length and longer. That would be excellent
Play episode from 08:52
Transcript
